Celligenics
Enabling Cellular Therapeutics.
Enabling Cellular Therapeutics.
Celligenics is a Singapore-based biotechnology startup founded in 2016. The company's slogan "Enabling Cellular Therapeutics" reflects its focus on leveraging stem cell technology to advance regenerative medicine. With a vision to become a global leader in the isolation and application of human stem cells and derivatives, Celligenics aims to revolutionize regenerative healthcare solutions. The company has received a SGD5.63M Series A investment from Best World International on 14 January 2019, showcasing its potential and attractiveness to investors. Celligenics brings a wealth of expertise in enterprise strategy, investment finance, research & development, as well as practical experience in molecular and cell biology to propel its mission forward. This positions the company as a promising player in the biotechnology landscape.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | SGD5.63M | 1 |
|
14 Jan 2019 |
No recent news or press coverage available for Celligenics.
We care about your data, and we'd love to use cookies make your experience better.
